EirGen Pharma employee successfully completes InterTrade Fusion propramme
Mr Ken O’Shea, Formulation Scientist at EirGen Pharma has successfully completed an 18 month FUSION project with the support of InterTrade Ireland. Ken’s project, in partnership with University of Ulster Coleraine, involved the use of an innovative chemical modification of a retinoid X receptor (RXR), and development of a novel solid dosage form technology as an oral drug delivery method in treating non-Hodgkin’s lymphoma.
Click the website link below for a recent interview conducted at EirGen Pharma with Ken by Intertrade Ireland.
EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets.